Innovation at BDThe Future and InnovationDiscover how we’re innovating to drive better outcomes for patients at critical moments throughout their livesLearn more
NEWSBD Receives FDA 510(k) Clearance for First-of-Its-Kind High-Throughput Diagnostic Test for Infectious VaginitisLearn More
BD Vaginal Panel on BD COR™ System Tests for Multiple Common Types of Vaginitis Using Only One Swab, One Test FRANKLIN LAKES, N.J., March 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and...
NEWSBD to Present at Barclays Global Healthcare ConferenceLearn More
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays Global Healthcare Conference on Wednesday, March...
NewsPatterns of Bacterial ResistanceListen as BD thought leaders Dr. Gupta and Dr. Yu give insights into patterns of rising bacterial resistance at a Health Watch USA Meeting on May 19, 2022Learn more